Tenaya Therapeutics, Inc.

Historical 13F Holders

Symbol
TNYA
CUSIP
87990A106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 87990A106 since 12/18/2024, largest first.

Filer % of Class Filed
Column Group III, LP 13D/A
23.1% 2/26/2026
Event 2/25/2026
Integrated Core Strategies (US) LLC 13G
5.2% 8/24/2026
Event 8/17/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Woodline Partners LP 13G/A 4.99% 8/14/2025
Event 6/30/2025
Empery Asset Management, LP 13G/A
4.99% 7/31/2025
Event 6/30/2025
Casdin Capital, LLC 13D/A
4.3% 3/7/2025
Event 3/4/2025
JPMorgan Chase & Co 13G/A 2.8% 3/6/2025
Event 2/28/2025
BlackRock, Inc. 13G/A 1.7% 7/16/2025
Event 6/30/2025
RA Capital Management, L.P. 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 969 k $585 k
2026 Q2 106 53.7 M $39.7 M
2026 Q1 109 56.3 M $38.9 M
2025 Q4 105 68.7 M $48.9 M
2025 Q3 98 34.6 M $55.6 M
2025 Q2 94 31.8 M $19.4 M
2025 Q1 110 48.6 M $27.7 M
2024 Q4 92 44.0 M $62.8 M
2024 Q3 99 57.7 M $111 M
2024 Q2 102 57.3 M $178 M
2024 Q1 97 56.7 M $296 M
2023 Q4 79 47.0 M $153 M
2023 Q3 81 50.8 M $129 M
2023 Q2 84 47.7 M $280 M
2023 Q1 69 45.0 M $128 M
2022 Q4 73 47.6 M $95.6 M
2022 Q3 76 35.3 M $102 M
2022 Q2 52 37.1 M $209 M
2022 Q1 52 37.4 M $441 M
2021 Q4 48 35.4 M $668 M
2021 Q3 48 33.9 M $693 M